Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Gilead/AbbVie Week 15/5 Script Numbers Reported By IMS Health

|Includes: ABBV, Gilead Sciences, Inc. (GILD)

Gilead (NASDAQ:GILD) week 15 script numbers.

Script Numbers Current Week Previous Week % Change
Harvoni TRx 7049 7035

0.0

Harvoni NRx 3627 3560 1.9
Harvoni/Sovaldi TRx 8962 8952 0.0
Harvoni/Sovaldi NRx

4450

4305 3.4

AbbVie (NYSE:ABBV) week 5 script numbers.

Script Numbers Current Week Previous Week % Change
Viekira Pak TRx 134 91 47.3
Viekira Pak NRx 120 90

33.3

RBC analyst Michael J. Yee reports, Based on our Harvoni-Viekira APP, we think GILD is on track to beat 2015 HCV estimates of $12-13 billion in the US and at least in-line with the Q4 estimates of $2.8-3.0 billion. ABBV's Viekira Pak scripts continue to be blocked, this is due to a contractual obligation between the supplier/manufacturer and the extent of the understatement continues to remain unknown at this time.

Disclosure: The author is long GILD.